Yotam Bronstein

869 total citations
12 papers, 63 citations indexed

About

Yotam Bronstein is a scholar working on Genetics, Infectious Diseases and Immunology. According to data from OpenAlex, Yotam Bronstein has authored 12 papers receiving a total of 63 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 4 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Yotam Bronstein's work include Chronic Lymphocytic Leukemia Research (7 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and COVID-19 Clinical Research Studies (4 papers). Yotam Bronstein is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and COVID-19 Clinical Research Studies (4 papers). Yotam Bronstein collaborates with scholars based in Israel, United States and Italy. Yotam Bronstein's co-authors include Yair Herishanu, Irit Avivi, Amos Adler, Shai Levi, Chava Perry, Ora Halutz, M. Morales, Paolo Ghia, Yair Herishanu and Gabi Shefer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Yotam Bronstein

12 papers receiving 63 citations

Peers

Yotam Bronstein

ONCOL

GENET

IMMUN

Vanessa Milogiannakis Australia

Anouschka Akerman Australia

Maxi Wass Germany

Renato Gammaldi Italy

Ludovica Cipriani Italy

Hlíf Steingrímsdóttir Iceland

Ivana Boďová Slovakia

Carmela Giancotta Italy

Yuichiro Inagaki Japan

Sachiko Ando Japan

Vanessa Milogiannakis Australia

Yotam Bronstein

25 ×0.9

25 ×1.2

ONCOL

34 ×1.8

GENET

15 ×1.1

27 ×2.1

IMMUN

Citations per year, relative to Yotam Bronstein Yotam Bronstein (= 1×) peers Vanessa Milogiannakis

Countries citing papers authored by Yotam Bronstein

Since Specialization

Citations

This map shows the geographic impact of Yotam Bronstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yotam Bronstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yotam Bronstein more than expected).

Fields of papers citing papers by Yotam Bronstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yotam Bronstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yotam Bronstein. The network helps show where Yotam Bronstein may publish in the future.

Co-authorship network of co-authors of Yotam Bronstein

This figure shows the co-authorship network connecting the top 25 collaborators of Yotam Bronstein. A scholar is included among the top collaborators of Yotam Bronstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yotam Bronstein. Yotam Bronstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Chodick, Gabriel, Lilac Tene, Yotam Bronstein, et al.. (2023). COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel. HemaSphere. 7(2). e839–e839. 1 indexed citations

Bronstein, Yotam, Shai Levi, & Yair Herishanu. (2023). Improved outcomes in patients with chronic lymphocytic leukaemia infected during the omicron BA.5 subvariant surge. British Journal of Haematology. 201(6). 1125–1128. 3 indexed citations

Levi, Shai, et al.. (2023). P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS. HemaSphere. 7(S3). e4811210–e4811210. 2 indexed citations

Bronstein, Yotam, et al.. (2022). Spatial organization and early signaling of the B-cell receptor in CLL. Frontiers in Immunology. 13. 953660–953660. 1 indexed citations

Bronstein, Yotam, Shai Levi, & Yair Herishanu. (2022). The Outcomes of Covid-19 in Patients with CLL during the Omicron Sub-Variants Surge. Blood. 140(Supplement 1). 7023–7024. 1 indexed citations

Bronstein, Yotam, et al.. (2022). REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection. SHILAP Revista de lepidopterología. 3(2). 471–474. 4 indexed citations

Katz, Ben‐Zion, Ronen Gabizon, Amit Shraga, et al.. (2021). Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells. Frontiers in Oncology. 11. 646971–646971. 13 indexed citations

Bronstein, Yotam, et al.. (2021). The Outcome of CLL Patients According to IGHV Mutational Status: An Israeli Perspective. Blood. 138(Supplement 1). 4686–4686. 1 indexed citations

Herishanu, Yair, Irit Avivi, Shai Levi, et al.. (2021). Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia. Blood Advances. 6(1). 148–151. 15 indexed citations

10.

Bronstein, Yotam, et al.. (2021). Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID‐19 infection. Journal of Medical Virology. 94(3). 1241–1245. 18 indexed citations

11.

Hod, Keren, Yotam Bronstein, Gabriel Chodick, & Ofer Shpilberg. (2020). Hemato-oncology Tourism in Israel: A Retrospective Review. JCO Global Oncology. 6(6). 1314–1320. 1 indexed citations

12.

Bronstein, Yotam, et al.. (2020). Characteristics and Outcomes of Patients Infected with SARS-CoV-2 in Israel: Correlation between Laboratory Findings on Admission to Emergency Department and Subsequent Respiratory Failure.. PubMed. 22(10). 605–611. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact